Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Apellis Pharmaceuticals, Inc. | 0 | reported | 14 May 2026 | tx 23+336,734−389,097 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 14 May 2026 | TENDER | Apellis Pharmaceuticals, Inc. | 86,525 | — | |
| 14 May 2026 | GRANT_AWARD | Apellis Pharmaceuticals, Inc. | 41,250 | — | |
| 14 May 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 41,250 | — | |
| 14 May 2026 | GRANT_AWARD | Apellis Pharmaceuticals, Inc. | 26,396 | — | |
| 14 May 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 26,396 | — | |
| 14 May 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 8,888 | — | |
| 14 May 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 12,723 | — | |
| 14 May 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 29,696 | — | |
| 14 May 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 82,500 | — | deriv |
| 14 May 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 49,000 | — | deriv |
| 14 May 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 37,000 | — | deriv |
| 22 Jan 2026 | SALE | Apellis Pharmaceuticals, Inc. | 2,797 | 21.77 USD | |
| 20 Jan 2026 | SALE | Apellis Pharmaceuticals, Inc. | 1,882 | 19.79 USD | |
| 05 Jan 2026 | SALE | Apellis Pharmaceuticals, Inc. | 3,020 | 25.53 USD | |
| 09 Jun 2025 | GRANT_AWARD | Apellis Pharmaceuticals, Inc. | 82,500 | 19.39 USD | deriv |
| 21 Jan 2025 | GRANT_AWARD | Apellis Pharmaceuticals, Inc. | 39,594 | 0.00 USD | |
| 17 Jan 2025 | SALE | Apellis Pharmaceuticals, Inc. | 1,853 | 29.96 USD | |
| 06 Jan 2025 | SALE | Apellis Pharmaceuticals, Inc. | 2,816 | 33.81 USD | |
| 16 Jan 2024 | GRANT_AWARD | Apellis Pharmaceuticals, Inc. | 25,445 | 0.00 USD | |
| 16 Jan 2024 | GRANT_AWARD | Apellis Pharmaceuticals, Inc. | 37,000 | 66.30 USD | deriv |
| 04 Jan 2024 | SALE | Apellis Pharmaceuticals, Inc. | 2,751 | 60.05 USD | |
| 03 Jan 2023 | GRANT_AWARD | Apellis Pharmaceuticals, Inc. | 35,549 | 0.00 USD | |
| 03 Jan 2023 | GRANT_AWARD | Apellis Pharmaceuticals, Inc. | 49,000 | 50.28 USD | deriv |